198 related articles for article (PubMed ID: 26148071)
21. Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease.
Djoussé L; Knowlton B; Hayden M; Almqvist EW; Brinkman R; Ross C; Margolis R; Rosenblatt A; Durr A; Dode C; Morrison PJ; Novelletto A; Frontali M; Trent RJ; McCusker E; Gómez-Tortosa E; Mayo D; Jones R; Zanko A; Nance M; Abramson R; Suchowersky O; Paulsen J; Harrison M; Yang Q; Cupples LA; Gusella JF; MacDonald ME; Myers RH
Am J Med Genet A; 2003 Jun; 119A(3):279-82. PubMed ID: 12784292
[TBL] [Abstract][Full Text] [Related]
22. Genetic Modification of Huntington Disease Acts Early in the Prediagnosis Phase.
Long JD; Lee JM; Aylward EH; Gillis T; Mysore JS; Abu Elneel K; Chao MJ; Paulsen JS; MacDonald ME; Gusella JF
Am J Hum Genet; 2018 Sep; 103(3):349-357. PubMed ID: 30122542
[TBL] [Abstract][Full Text] [Related]
23. Glutathione S-Transferase Omega 1 variation does not influence age at onset of Huntington's disease.
Arning L; Jagiello P; Wieczorek S; Saft C; Andrich J; Epplen JT
BMC Med Genet; 2004 Mar; 5():7. PubMed ID: 15040808
[TBL] [Abstract][Full Text] [Related]
24. Gene expression profiles complement the analysis of genomic modifiers of the clinical onset of Huntington disease.
Wright GEB; Caron NS; Ng B; Casal L; Casazza W; Xu X; Ooi J; Pouladi MA; Mostafavi S; Ross CJD; Hayden MR
Hum Mol Genet; 2020 Sep; 29(16):2788-2802. PubMed ID: 32898862
[TBL] [Abstract][Full Text] [Related]
25. Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region.
Lee JM; Gillis T; Mysore JS; Ramos EM; Myers RH; Hayden MR; Morrison PJ; Nance M; Ross CA; Margolis RL; Squitieri F; Griguoli A; Di Donato S; Gomez-Tortosa E; Ayuso C; Suchowersky O; Trent RJ; McCusker E; Novelletto A; Frontali M; Jones R; Ashizawa T; Frank S; Saint-Hilaire MH; Hersch SM; Rosas HD; Lucente D; Harrison MB; Zanko A; Abramson RK; Marder K; Sequeiros J; MacDonald ME; Gusella JF
Am J Hum Genet; 2012 Mar; 90(3):434-44. PubMed ID: 22387017
[TBL] [Abstract][Full Text] [Related]
26. Exploring the correlates of intermediate CAG repeats in Huntington disease.
Ha AD; Jankovic J
Postgrad Med; 2011 Sep; 123(5):116-21. PubMed ID: 21904093
[TBL] [Abstract][Full Text] [Related]
27. Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: the HD MAPS study.
Li JL; Hayden MR; Warby SC; Durr A; Morrison PJ; Nance M; Ross CA; Margolis RL; Rosenblatt A; Squitieri F; Frati L; Gómez-Tortosa E; García CA; Suchowersky O; Klimek ML; Trent RJ; McCusker E; Novelletto A; Frontali M; Paulsen JS; Jones R; Ashizawa T; Lazzarini A; Wheeler VC; Prakash R; Xu G; Djoussé L; Mysore JS; Gillis T; Hakky M; Cupples LA; Saint-Hilaire MH; Cha JH; Hersch SM; Penney JB; Harrison MB; Perlman SL; Zanko A; Abramson RK; Lechich AJ; Duckett A; Marder K; Conneally PM; Gusella JF; MacDonald ME; Myers RH
BMC Med Genet; 2006 Aug; 7():71. PubMed ID: 16914060
[TBL] [Abstract][Full Text] [Related]
28. Failure to confirm influence of methyltetrahydrofolate reductase (MTHFR) polymorphisms on age at onset of Huntington disease.
Hansen W; Saft C; Andrich J; Müller T; Wieczorek S; Epplen JT; Arning L
J Negat Results Biomed; 2005 Dec; 4():12. PubMed ID: 16372906
[TBL] [Abstract][Full Text] [Related]
29. Age at onset in Huntington's disease: replication study on the associations of ADORA2A, HAP1 and OGG1.
Taherzadeh-Fard E; Saft C; Wieczorek S; Epplen JT; Arning L
Neurogenetics; 2010 Oct; 11(4):435-9. PubMed ID: 20512606
[TBL] [Abstract][Full Text] [Related]
30. [Clinical characteristics of Huntington disease in two pedigrees and analysis of expanded CAG trinucleotide repeat].
Cao GN; Bao XH; Lu HM; Zhang JJ; Ma YN; Gu WH; Xiong H; Qin J; Wu XR
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):163-7. PubMed ID: 21503105
[TBL] [Abstract][Full Text] [Related]
31. A retrospective study of the impact of lifestyle on age at onset of Huntington disease.
Trembath MK; Horton ZA; Tippett L; Hogg V; Collins VR; Churchyard A; Velakoulis D; Roxburgh R; Delatycki MB
Mov Disord; 2010 Jul; 25(10):1444-50. PubMed ID: 20629137
[TBL] [Abstract][Full Text] [Related]
32. The hOGG1 Ser326Cys polymorphism and Huntington's disease.
Coppedè F; Migheli F; Ceravolo R; Bregant E; Rocchi A; Petrozzi L; Unti E; Lonigro R; Siciliano G; Migliore L
Toxicology; 2010 Dec; 278(2):199-203. PubMed ID: 19857538
[TBL] [Abstract][Full Text] [Related]
33. Population-specific genetic modification of Huntington's disease in Venezuela.
Chao MJ; Kim KH; Shin JW; Lucente D; Wheeler VC; Li H; Roach JC; Hood L; Wexler NS; Jardim LB; Holmans P; Jones L; Orth M; Kwak S; MacDonald ME; Gusella JF; Lee JM
PLoS Genet; 2018 May; 14(5):e1007274. PubMed ID: 29750799
[TBL] [Abstract][Full Text] [Related]
34. Clinical and genetic data of Huntington disease in Moroccan patients.
Bouhouche A; Regragui W; Lamghari H; Khaldi K; Birouk N; Lytim S; Bellamine S; Kriouile Y; Bouslam N; Haddou el HA; Faris MA; Benomar A; Yahyaoui M
Afr Health Sci; 2015 Dec; 15(4):1232-8. PubMed ID: 26958025
[TBL] [Abstract][Full Text] [Related]
35. The p. R151C Polymorphism in MC1R Gene Modifies the Age of Onset in Spanish Huntington's Disease Patients.
Tell-Marti G; Puig-Butille JA; Gimenez-Xavier P; Segu-Roig A; Potrony M; Badenas C; Alvarez V; Millán JM; Trujillo-Tiebas MJ; Ramos-Arroyo MA; Milà M; Puig S
Mol Neurobiol; 2017 Jul; 54(5):3906-3910. PubMed ID: 27924526
[TBL] [Abstract][Full Text] [Related]
36. Modulation of age at onset in Huntington's disease and spinocerebellar ataxia type 2 patients originated from eastern India.
Chattopadhyay B; Ghosh S; Gangopadhyay PK; Das SK; Roy T; Sinha KK; Jha DK; Mukherjee SC; Chakraborty A; Singhal BS; Bhattacharya AK; Bhattacharyya NP
Neurosci Lett; 2003 Jul; 345(2):93-6. PubMed ID: 12821179
[TBL] [Abstract][Full Text] [Related]
37. A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS study.
Li JL; Hayden MR; Almqvist EW; Brinkman RR; Durr A; Dodé C; Morrison PJ; Suchowersky O; Ross CA; Margolis RL; Rosenblatt A; Gómez-Tortosa E; Cabrero DM; Novelletto A; Frontali M; Nance M; Trent RJ; McCusker E; Jones R; Paulsen JS; Harrison M; Zanko A; Abramson RK; Russ AL; Knowlton B; Djoussé L; Mysore JS; Tariot S; Gusella MF; Wheeler VC; Atwood LD; Cupples LA; Saint-Hilaire M; Cha JH; Hersch SM; Koroshetz WJ; Gusella JF; MacDonald ME; Myers RH
Am J Hum Genet; 2003 Sep; 73(3):682-7. PubMed ID: 12900792
[TBL] [Abstract][Full Text] [Related]
38. 4p16.3 haplotype modifying age at onset of Huntington disease.
Nørremølle A; Budtz-Jørgensen E; Fenger K; Nielsen JE; Sørensen SA; Hasholt L
Clin Genet; 2009 Mar; 75(3):244-50. PubMed ID: 19250382
[TBL] [Abstract][Full Text] [Related]
39. A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington disease.
Bečanović K; Nørremølle A; Neal SJ; Kay C; Collins JA; Arenillas D; Lilja T; Gaudenzi G; Manoharan S; Doty CN; Beck J; Lahiri N; Portales-Casamar E; Warby SC; Connolly C; De Souza RA; ; Tabrizi SJ; Hermanson O; Langbehn DR; Hayden MR; Wasserman WW; Leavitt BR
Nat Neurosci; 2015 Jun; 18(6):807-16. PubMed ID: 25938884
[TBL] [Abstract][Full Text] [Related]
40. Haplotype analysis of the CAG and CCG repeats in 21 Brazilian families with Huntington's disease.
Agostinho Lde A; Rocha CF; Medina-Acosta E; Barboza HN; da Silva AF; Pereira SP; da Silva Idos S; Paradela ER; Figueiredo AL; Nogueira Ede M; Alvarenga RM; Hernan Cabello P; dos Santos SR; Paiva CL
J Hum Genet; 2012 Dec; 57(12):796-803. PubMed ID: 23051704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
